Bennett Ma

2.0k citations

38 papers · 1.6k indexed · h-index 16

Impact in

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Oncology top 5%
- Drug Transport and Resistance Mechanisms

Papers in ⓘ

Pharmacology 16
- Pharmacogenetics and Drug Metabolism 13
- Drug-Induced Hepatotoxicity and Protection 3
Molecular Biology 15
- Receptor Mechanisms and Signaling 4
- Bone Metabolism and Diseases 4

Co-authors: Thomayant Prueksaritanont (11 shared papers)Jiunn H. Lin (7 shared papers)Thomas A. Baillie (3 shared papers)Paul G. Pearson (2 shared papers)Yue Qiu (2 shared papers)Nathan X. Yu (2 shared papers)Lida Liu (2 shared papers)Raju Subramanian (4 shared papers)
Journals: Drug Metabolism and Disposition (9 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Xenobiotica (2 papers)British Journal of Clinical Pharmacology (2 papers)
Partner nations: United States Switzerland Japan

In The Last Decade

Bennett Ma

38 papers receiving 1.5k citations

Peers

Countries citing papers authored by Bennett Ma

Since Specialization

Citations

This map shows the geographic impact of Bennett Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bennett Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bennett Ma more than expected).

Fields of papers citing papers by Bennett Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bennett Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bennett Ma. The network helps show where Bennett Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Bennett Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bennett Ma Line = papers co-authored together Bennett Ma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization Drug Metabolism and Disposition ·Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson, Thomas A. Baillie	2002	276
2	In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. PubMed ·Thomayant Prueksaritanont, Lynn M. Gorham, Bennett Ma, Lida Liu, Xiaoming Yu, J J Zhao, Donald E. Slaughter, Byron H. Arison, Kamlesh P. Vyas	1997	244
3	Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins Journal of Pharmacology and Experimental Therapeutics ·Thomayant Prueksaritanont, Jamie J. Zhao, Bennett Ma, Brad Roadcap, Cuyue Tang, Yue Qiu, Lida Liu, Jiunn H. Lin, Paul G. Pearson, Thomas A. Baillie	2002	219
4	The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6 British Journal of Clinical Pharmacology ·Thomayant Prueksaritanont, Bennett Ma, Nathan X. Yu	2003	145
5	Drug Interactions with Calcium Channel Blockers: Possible Involvement of Metabolite-Intermediate Complexation with CYP3A Drug Metabolism and Disposition ·Bennett Ma, Thomayant Prueksaritanont, Jiunn H. Lin	2000	141
6	Metabolic interactions between mibefradil and HMG‐CoA reductase inhibitors: an in vitro investigation with human liver preparations British Journal of Clinical Pharmacology ·Thomayant Prueksaritanont, Bennett Ma, Cuyue Tang, Meng Yuan, Carol Assang, Ping Lü, Paul J. Reider, Jiunn H. Lin, Thomas A. Baillie	1999	81
7	The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma Clinical Cancer Research ·Jenny L. Pokorny, David Calligaris, Shiv K. Gupta, Dennis O. Iyekegbe, Dustin Mueller, Katrina K. Bakken, Brett L. Carlson, Mark A. Schroeder, Debra L. Evans, Zhenkun Lou, Paul A. Decker, Jeanette E. Eckel‐Passow, Vincenzo Pucci, Bennett Ma, Stuart D. Shumway, William F. Elmquist, Nathalie Y.R. Agar, Jann N. Sarkaria	2015	71
8	SULFOTRANSFERASE 1E1 IS A LOW KM ISOFORM MEDIATING THE 3-O-SULFATION OF ETHINYL ESTRADIOL Drug Metabolism and Disposition ·Michael Schrag, Donghui Cui, Thomas H. Rushmore, Magang Shou, Bennett Ma, A. David Rodrigues	2004	45
9	Acyl Glucuronidation and Glucosidation of a New and Selective Endothelin ETA Receptor Antagonist in Human Liver Microsomes Drug Metabolism and Disposition ·Cuyue Tang, Jerome Hochman, Bennett Ma, Raju Subramanian, Kamlesh P. Vyas	2003	35
10	SOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITRO Drug Metabolism and Disposition ·Bennett Ma, Magang Shou, Michael Schrag	2003	30
11	beta-Oxidation of simvastatin in mouse liver preparations. PubMed ·Thomayant Prueksaritanont, Bennett Ma, Xiaojun Fang, Raju Subramanian, Jiangbo Yu, J H Lin	2001	30
12	Discovery of tetrahydropyridopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia Bioorganic & Medicinal Chemistry Letters ·Izzat T. Raheem, Michael J. Breslin, Christine Fandozzi, Joy Fuerst, Nicole Hill, Sarah L. Huszar, Monika Kandebo, Somang H. Kim, Bennett Ma, Georgia B. McGaughey, John J. Renger, John D. Schreier, Sujata Sharma, Sean M. Smith, Jason M. Uslaner, Youwei Yan, Paul J. Coleman, Christopher D. Cox	2012	25
13	Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia Journal of Medicinal Chemistry ·M. E. Layton, Jeffrey C. Kern, Timothy J. Hartingh, William D. Shipe, Izzat T. Raheem, Monika Kandebo, Robert P. Hayes, Sarah L. Huszar, Donnie Eddins, Bennett Ma, Joy Fuerst, Gordon K. Wollenberg, Jing Li, Jeff Fritzen, Georgia B. McGaughey, Jason M. Uslaner, Sean M. Smith, Paul J. Coleman, Christopher D. Cox	2023	22
14	Purification and cloning of a Delta class glutathioneS‐transferase displaying high peroxidase activity isolated from the German cockroachBlattella germanica FEBS Journal ·Bennett Ma, F.N. Chang	2007	22
15	In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318. Roles of efflux and metabolism. PubMed ·Thomayant Prueksaritanont, Polly DeLuna, Lynn M. Gorham, Bennett Ma, Dosinda Cohn, Jianmei Pang, Xin Xu, Kwan Leung, Jiunn H. Lin	1998	20
16	Discovery of GlyT1 inhibitors with improved pharmacokinetic properties Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg, Zhijian Zhao, David D. Wisnoski, William Leister, Julie L. O'Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, Christopher R. Gibson, Bennett Ma, Stacey L. Polsky-Fisher, Craig W. Lindsley, George D. Hartman	2009	15
17	Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor Drug Metabolism and Disposition ·Cheri M. Maciolek, Bennett Ma, Karsten Menzel, Sébastien Laliberté, Kevin P. Bateman, Paul Krolikowski, Christopher R. Gibson	2011	12
18	Reaction Phenotyping of Low-Turnover Compounds in Long-Term Hepatocyte Cultures Through Persistent Selective Inhibition of Cytochromes P450 Drug Metabolism and Disposition ·Sheri Smith, Michael Lyman, Bennett Ma, Donald Tweedie, Karsten Menzel	2021	10
19	Characterization of the absorption, metabolism, excretion, and mass balance of gefapixant in humans Pharmacology Research & Perspectives ·Jesse C. Nussbaum, Azher Hussain, Bennett Ma, K. Chris Min, Qing Chen, Charles Tomek, Marian Iwamoto, S. Aubrey Stoch	2022	10
20	Applicability of in vitro-in vivo translation of cathepsin K inhibition from animal species to human with the use of free-drug hypothesis Naunyn-Schmiedeberg s Archives of Pharmacology ·Bennett Ma, Bin Luo, Danielle H. Euler, Tara E. Cusick, Gregg Wesolowski, Helmut Glantschnig, Le T. Duong, Yangsi Ou, Steven S. Carroll, Laura S. Lubbers	2017	9

About Bennett Ma

Bennett Ma is a scholar working on Pharmacology, Molecular Biology, Oncology, Surgery and Pharmacology, having authored 38 papers that have together received 1.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (13 papers), Receptor Mechanisms and Signaling (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Bone Metabolism and Diseases (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Computational Drug Discovery Methods (3 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). The work is most often cited by research in Pharmacology (616 citations), Oncology (467 citations), Computational Theory and Mathematics (194 citations), Endocrinology, Diabetes and Metabolism (186 citations) and Surgery (489 citations). Bennett Ma has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Thomayant Prueksaritanont, Jiunn H. Lin, Thomas A. Baillie, Paul G. Pearson, Yue Qiu, Nathan X. Yu, Lida Liu, Raju Subramanian, Xiaojun Fang and Cuyue Tang. Their work appears in journals such as Drug Metabolism and Disposition, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Xenobiotica and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact